Non-Alcoholic Fatty Liver Disease for the Primary Care Clinician

On-Demand Webinar   |   Nov. 15, 2018

 

fatty liver 1.png
 

+

CME CREDITS: 0.0 (no longer eligible)

CME Participation Waiver *
By registering for the webinar, you are confirming that you agree to the waiver available at the bottom of this page.

FACULTY:  ETHAN BORTNIKER, MD

Assistant Professor of Medicine Gastroentrology, UConn Health Director of Colorectal Clinical Research, UConn Health

 

Dr. Ethan Bortniker is an Assistant Professor of Medicine and Director of Colorectal Clinical Research at UConn Health. He is a graduate of Boston University School of Medicine. He completed his internal medicine residency at Boston University Medical Center and Gastroenterology fellowship training at the UConn School of Medicine. Dr. Bortniker is board-certified in internal medicine and gastroenterology. His areas of expertise are colorectal cancer prevention and motility disorders, and research interests include fecal microbiome and cancers of the GI tract.

ethan_bortniker.png

OVERVIEW

Non-Alcoholic Fatty Liver Disease (NAFLD) is hepatic steatosis on imaging or histology in the absence of other causes of steatosis. It is frequently diagnosed when the patient is found to have an elevation in transaminase levels or as an incidental finding on imaging. It is estimated that the prevalence of NAFLD in the United States is 30%. Approximately 10-30% of patients with NAFLD develop non-alcoholic steatohepatitis which is associated with increased mortality due to the development of cirrhosis and hepatocellular carcinoma. In this webinar, Dr. Ethan Bortniker, M.D., will review the natural history of Non-Alcoholic Fatty Liver Disease; define the epidemiology and recognize the risk factors of Non-Alcoholic Fatty Liver Disease that may present in primary care; and identify the various diagnostic and management options available to patients with Non-Alcoholic Fatty Liver Disease.


LECTURE FORMAT

This lecture will be conducted as a one-hour live webinar. Registration is free. Participants will submit a survey at the end of the session to claim CME credit.

COURSE CHAIRS

  • J. Nwando Olayiwola, MD, MPH, FAAFP

  • Anna Potapov, MD, MPH, MBA

  • Marc E. Walker, MD, MBA

  • Pooja Mittal, DO

 

LEARNING OBJECTIVES

By the end of the event, participants should:

  1. Become familiar with the natural history of Non-Alcoholic Fatty Liver Disease

  2. Define the epidemiology and recognize the risk factors of Non-Alcoholic Fatty Liver Disease that may present in primary care

  3. Review the various diagnostic and management options available to patients with Non-Alcoholic Fatty Liver Disease